Browse By Cell Line Result Page of OvirusTdb

The total number of records retrieved from this search are 26. Click on ID to see further detail.
IDVirus nameVirus strainVirus genome typeVirus familyVirus genome modificationVirus aloneVirus in combination with drug/radiationImmune gene insertion in viral genomeSource of cell lineOrigin of cell lineCell lineConcentration of cell lineIn-vitro toxicityAssayIn-vitro virus concentrationIn-vitro resultModel organismIn-vivo virus concentrationIn-vivo toxicityIn-vivo resultMode of deliveryPathway inducedImmunogenic effectClinical trialPMID
OV_1443ReovirusReoT3DRNAReoviridaeNoneYesNoNoNCIHuman NSCLC cell lineNCIH460NANAXTT assayLog10 pfu/cell20% cell survived 48 hours after post infectionNoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19594950
OV_1452ReovirusReoT3DRNAReoviridaeNoneNoVirus strain in combination with palcitaxel (100 micromolar)NoNCIHuman NSCLC cell lineNCIH460NANADose response analysis curveLog10 pfu/cell100% cell death after 4 daysNoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19594950
OV_1453ReovirusReoT3DRNAReoviridaeNoneNoVirus in combination with palcitaxel (0.003 +/- 0.001 micromolar, 1:53)NoNCIHuman NSCLC cell lineNCIH460NANAchou-Talay analysisLog10 pfu/cell50% cell death occurs at 0.903 CI valueNoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19594950
OV_1459ReovirusReoT3DRNAReoviridaeNoneNoVirus in combination with palcitaxel (0.003 +/- 0.001 micromolar, 1:53)NoNCIHuman NSCLC cell lineNCIH460NANAchou-Talay analysisLog10 pfu/cell75% cell death at CI value 0.221NoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19594950
OV_1465ReovirusReoT3DRNAReoviridaeNoneNoVirus in combination with palcitaxel (0.003 +/- 0.001 micromolar, 1:53)NoNCIHuman NSCLC cell lineNCIH460NANAchou-Talay analysisLog10 pfu/cell90% cell death at CI value 0.057NoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19594950
OV_1471ReovirusReoT3DRNAReoviridaeNoneNoVirus in combination with palcitaxel (0.003 +/- 0.001 micromolar, 1:533)NoNCIHuman NSCLC cell lineNCIH460NANAchou-Talay analysisLog10 pfu/cell50% cell death occurs at 0.193 CI valueNoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19594950
OV_1477ReovirusReoT3DRNAReoviridaeNoneNoVirus in combination with palcitaxel (0.003 +/- 0.001 micromolar, 1:533)NoNCIHuman NSCLC cell lineNCIH460NANAchou-Talay analysisLog10 pfu/cell75% cell death at CI value 0.042NoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19594950
OV_1483ReovirusReoT3DRNAReoviridaeNoneNoVirus in combination with palcitaxel (0.003 +/- 0.001 micromolar, 1:533)NoNCIHuman NSCLC cell lineNCIH460NANAchou-Talay analysisLog10 pfu/cell90% cell death at CI value 0.013NoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19594950
OV_1489ReovirusReoT3DRNAReoviridaeNoneNoVirus combination with cisplatin (5.31+/-1.21, ratio is 1:53)NoNCIHuman NSCLC cell lineNCIH460NANAchou-Talay analysisLog10 pfu/cell50% cell death at CI value 0.875NoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19594950
OV_1495ReovirusReoT3DRNAReoviridaeNoneNoVirus combination with cisplatin (5.31+/-1.21, ratio is 1:53)NoNCIHuman NSCLC cell lineNCIH460NANAchou-Talay analysisLog10 pfu/cell75% death at CI value 0.313NoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19594950
OV_1501ReovirusReoT3DRNAReoviridaeNoneNoVirus combination with cisplatin (5.31+/-1.21, ratio is 1:53)NoNCIHuman NSCLC cell lineNCIH460NANAchou-Talay analysisLog10 pfu/cell90% cell death at CI value 0.112NoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19594950
OV_1507ReovirusReoT3DRNAReoviridaeNoneNoVirus combination with cisplatin (5.31+/-1.21, ratio is 1:533)NoNCIHuman NSCLC cell lineNCIH460NANAchou-Talay analysisLog10 pfu/cell50% cell death at CI value 0.061NoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19594950
OV_1513ReovirusReoT3DRNAReoviridaeNoneNoVirus combination with cisplatin (5.31+/-1.21, ratio is 1:533)NoNCIHuman NSCLC cell lineNCIH460NANAchou-Talay analysisLog10 pfu/cell75% death at CI value 0.006NoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19594950
OV_1519ReovirusReoT3DRNAReoviridaeNoneNoVirus combination with cisplatin (5.31+/-1.21, ratio is 1:533)NoNCIHuman NSCLC cell lineNCIH460NANAchou-Talay analysisLog10 pfu/cell90% cell death at CI value 0.129NoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19594950
OV_1525ReovirusReoT3DRNAReoviridaeNoneNoVirus in combination with Gemcitabine (0.01+/- 0.003, 1:53)NoNCIHuman NSCLC cell lineNCIH460NANAchou-Talay analysisLog10 pfu/cell50% cell death at CI value 0.199NoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19594950
OV_1531ReovirusReoT3DRNAReoviridaeNoneNoVirus in combination with Gemcitabine (0.01+/- 0.003, 1:53)NoNCIHuman NSCLC cell lineNCIH460NANAchou-Talay analysisLog10 pfu/cell75 % cell death at CI 0.126NoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19594950
OV_1537ReovirusReoT3DRNAReoviridaeNoneNoVirus in combination with Gemcitabine (0.01+/- 0.003, 1:53)NoNCIHuman NSCLC cell lineNCIH460NANAchou-Talay analysisLog10 pfu/cell90% cell killing at CI 0.126NoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19594950
OV_1543ReovirusReoT3DRNAReoviridaeNoneNoVirus in combination with Gemcitabine (0.01+/- 0.003, 1:533)NoNCIHuman NSCLC cell lineNCIH460NANAchou-Talay analysisLog10 pfu/cell50% cell killing at CI 0.006NoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19594950
OV_1549ReovirusReoT3DRNAReoviridaeNoneNoVirus in combination with Gemcitabine (0.01+/- 0.003, 1:533)NoNCIHuman NSCLC cell lineNCIH460NANAchou-Talay analysisLog10 pfu/cell75% cell killing at CI 0.017NoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19594950
OV_1555ReovirusReoT3DRNAReoviridaeNoneNoVirus in combination with Gemcitabine (0.01+/- 0.003, 1:533)NoNCIHuman NSCLC cell lineNCIH460NANAchou-Talay analysisLog10 pfu/cell90% cell killing at CI 0.054NoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19594950
OV_1561ReovirusReoT3DRNAReoviridaeNoneNoVirus combination with vinblastine(0.92+/-0.35nm, 1:5.3)NoNCIHuman NSCLC cell lineNCIH460NANAchou-Talay analysisLog10 pfu/cell50% cell killing at CI 0.255NoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19594950
OV_1567ReovirusReoT3DRNAReoviridaeNoneNoVirus combination with vinblastine(0.92+/-0.35nm, 1:5.3)NoNCIHuman NSCLC cell lineNCIH460NANAchou-Talay analysisLog10 pfu/cell75% cell killing at CI 0.149NoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19594950
OV_1573ReovirusReoT3DRNAReoviridaeNoneNoVirus combination with vinblastine(0.92+/-0.35nm, 1:5.3)NoNCIHuman NSCLC cell lineNCIH460NANAchou-Talay analysisLog10 pfu/cell90% cell killing at CI 0.089NoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19594950
OV_1579ReovirusReoT3DRNAReoviridaeNoneNoVirus combination with vinblastine(0.92+/-0.35nm, 1:53.3)NoNCIHuman NSCLC cell lineNCIH460NANAchou-Talay analysisLog10 pfu/cell50% cell killing at CI 0.069NoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19594950
OV_1585ReovirusReoT3DRNAReoviridaeNoneNoVirus combination with vinblastine(0.92+/-0.35nm, 1:53.3)NoNCIHuman NSCLC cell lineNCIH460NANAchou-Talay analysisLog10 pfu/cell75% cell killing at CI 0.045NoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19594950
OV_1591ReovirusReoT3DRNAReoviridaeNoneNoVirus combination with vinblastine(0.92+/-0.35nm, 1:53.3)NoNCIHuman NSCLC cell lineNCIH460NANAchou-Talay analysisLog10 pfu/cell90% cell killing at CI 0.031NoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19594950